drugset / Trial / NCT05694169
A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of supplemental REACT injections in participants with chronic kidney disease (CKD) who have previously received REACT treatment.
Timeline
- Start
- 2023-07-11
- Primary completion
- 2024-03-19
- Completion
- 2024-05-13
Outcome
Outcome not reported
Stopped (Business): “business decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REACT | Cell therapy | — | — |